AUG 15, 2026 · JOURNAL ARTICLE
Prognostic value of tissue-based DNA methylation biomarkers in non-small cell lung cancer: a systematic review
BMC Cancer
Systematic review of 20 studies confirming that tissue-based DNA methylation is frequently associated with worse survival in NSCLC, but methodological heterogeneity and lack of meta-analysis prevent definitive clinical recommendations.
Important Confirmatory EvidenceHistone Deacetylase Inhibitors ResearchLung Cancer Treatments and MutationsEpigenetics and DNA Methylation
Reported
Proportion of adverse associations77.5% (31/40)
miR-34b/c hazard ratio3.34
EGLN2 hazard ratio1.71